Gene expression profiling predicts survival in conventional renal cell carcinoma

PLoS Medicine

Volumn 3, Issue 1, 2006, Pages 115-124

  Zhao, Hongjuan ^a   Ljungberg, Börje ^b   Grankvist, Kjell ^b   Rasmuson, Torgny ^b   Tibshirani, Robert ^a   Brooks, James D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; TASK PERFORMANCE; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, RENAL CELL; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SURVIVAL ANALYSIS;

EID: 32144434202     PISSN: 15491277     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030013     Document Type: Article

References (29)

1. Vogelzang NJ, Stadler WM (1998) Kidney cancer. Lancet 352: 1691-1696.
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55: 10-30.
3. Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, et al. (2001) Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345: 1655-1659.
4. Negrier S, Escudier B, Lasset C, Douillard JY, Savary J, et al. (1998) Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. N Engl J Med 338: 1272-1278.
5. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, et al. (2003) A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol 170: 2225-2232.
6. Patard JJ, Kim HL, Lam JS, Dorey FJ, Pantuck AJ, et al. (2004) Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: An international multicenter study. J Clin Oncol 22: 3316-3322.
7. Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, et al. (2005) A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173: 48-51.
8. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, et al. (2001) Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification. Proc Natl Acad Sci U S A 98: 9754-9759.
9. Vasselli JR, Shih JH, Iyengar SR, Maranchie J, Riss J, et al. (2003) Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci U S A 100: 6958-6963.
10. Boer JM, Huber WK, Sultmann H, Wilmer F, von Heydebreck A, et al. (2001) Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res 11: 1861-1870.
11. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, et al. (2004) Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350: 1605-1616.
12. Gollub J, Ball CA, Binkley G, Demeter J, Finkelstein DB, et al. (2003) The Stanford Microarray Database: Data access and quality assessment tools. Nucleic Acids Res 31: 94-96.
13. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
14. Bair E, Hastie T, Debashis P, Tibshirani R (2005) Prediction by supervised principal components. J Am Stat Assoc. In press.
15. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, et al. (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7: 85-90.
16. Ivan M, Kondo K, Yang H, Kim W, Valiando J, et al. (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292: 464-468.
17. Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, et al. (2003) Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 162: 925-932.
18. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
19. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large B cell lymphoma. N Engl J Med 346: 1937-1947.
20. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54.
21. Bair E, Tibshirani R (2004) Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol 2: e108. DOI: 10.1371/journal. pbio.0020108
22. Bair E (2004) Semi-supervised methods for predicting patient survival from microarray data [dissertation]. Stanford (California): Stanford University.
23. Ben-Tovim Jones L, Ng SK, Ambroise C, Monico K, Khan N, et al. (2005) Use of microarray data via model-based classification in the study and prediction of survival from lung cancer. In: Shoemaker JS, Lin SM, editors. Methods of microarray data analysis IV. New York: Springer. pp. 163-173.
24. Schuetz AN, Yin-Goen Q, Amin MB, Moreno CS, Cohen C, et al. (2005) Molecular classification of renal tumors by gene expression profiling. J Mol Diagn 7: 206-218.
25. Yao M, Tabuchi H, Nagashima Y, Baba M, Nakaigawa N, et al. (2005) Gene expression analysis of renal carcinoma: Adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol 205: 377-387.
26. Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, et al. (2003) Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy. Clin Cancer Res 9: 802-811.
27. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A geneexpression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
28. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, et al. (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 350: 1828-1837.
29. Paik S, Shak S, Tang G, Kim C, Baker J, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826.